Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.
2.

Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.

Engels EA, Viscidi RP, Galloway DA, Carter JJ, Cerhan JR, Davis S, Cozen W, Severson RK, de Sanjose S, Colt JS, Hartge P.

J Natl Cancer Inst. 2004 Sep 15;96(18):1368-74.

3.

Association between SV40 and non-Hodgkin's lymphoma.

Butel JS, Vilchez RA, Jorgensen JL, Kozinetz CA.

Leuk Lymphoma. 2003;44 Suppl 3:S33-9. Review.

PMID:
15202523
4.

Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphoma.

Engels EA, Chen J, Hartge P, Cerhan JR, Davis S, Severson RK, Cozen W, Viscidi RP.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):521-4.

5.

High prevalence of SV40 infection in patients with nodal non-Hodgkin's lymphoma but not acute leukemia independent of contaminated polio vaccines in Taiwan.

Chen PM, Yen CC, Yang MH, Poh SB, Hsiao LT, Wang WS, Lin PC, Lee MY, Teng HW, Bai LY, Chu CJ, Chao SC, Yang AH, Chiou TJ, Liu JH, Chao TC.

Cancer Invest. 2006 Apr-May;24(3):223-8.

PMID:
16809147
6.

Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort.

Rollison DE, Helzlsouer KJ, Halsey NA, Shah KV, Viscidi RP.

Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1448-52.

7.

Absence of simian virus 40 (SV40) DNA in lymphoma samples from Tasmania, Australia.

Sui LF, Williamson J, Lowenthal RM, Parker AJ.

Pathology. 2005 Apr;37(2):157-9.

PMID:
16028845
8.

Is there a role for SV40 in human cancer?

Poulin DL, DeCaprio JA.

J Clin Oncol. 2006 Sep 10;24(26):4356-65. Review.

PMID:
16963733
9.

Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma.

Engels EA, Rodman LH, Frisch M, Goedert JJ, Biggar RJ.

Int J Cancer. 2003 Aug 20;106(2):283-7.

10.

Lack of serologic evidence for prevalent simian virus 40 infection in humans.

Carter JJ, Madeleine MM, Wipf GC, Garcea RL, Pipkin PA, Minor PD, Galloway DA.

J Natl Cancer Inst. 2003 Oct 15;95(20):1522-30.

11.

Detection of simian virus 40 DNA sequences in Egyptian patients with different hematological malignancies.

Zekri AR, Mohamed W, Bahnassy A, Refat L, Khaled M, Shalaby S, Hafez M.

Leuk Lymphoma. 2007 Sep;48(9):1828-34.

PMID:
17786720
12.

Simian virus 40 in human cancers.

Vilchez RA, Kozinetz CA, Arrington AS, Madden CR, Butel JS.

Am J Med. 2003 Jun 1;114(8):675-84.

PMID:
12798456
13.

Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma.

Vilchez RA, Lednicky JA, Halvorson SJ, White ZS, Kozinetz CA, Butel JS.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):109-16.

PMID:
11832678
14.

Cell and molecular biology of simian virus 40: implications for human infections and disease.

Butel JS, Lednicky JA.

J Natl Cancer Inst. 1999 Jan 20;91(2):119-34. Review.

15.

Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association.

Dang-Tan T, Mahmud SM, Puntoni R, Franco EL.

Oncogene. 2004 Aug 23;23(38):6535-40. Review.

PMID:
15322523
16.

Causality of mesothelioma: SV40 question.

Shah KV.

Thorac Surg Clin. 2004 Nov;14(4):497-504.

PMID:
15559056
17.

Association between simian virus 40 DNA and lymphoma in the United kingdom.

MacKenzie J, Wilson KS, Perry J, Gallagher A, Jarrett RF.

J Natl Cancer Inst. 2003 Jul 2;95(13):1001-3.

18.

SV40 in human brain cancers and non-Hodgkin's lymphoma.

Vilchez RA, Butel JS.

Oncogene. 2003 Aug 11;22(33):5164-72. Review.

PMID:
12910253
19.

The role of SV40 in malignant mesothelioma and other human malignancies.

Pershouse MA, Heivly S, Girtsman T.

Inhal Toxicol. 2006 Nov;18(12):995-1000. Review.

PMID:
16920674
20.

Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40.

Engels EA, Katki HA, Nielsen NM, Winther JF, Hjalgrim H, Gjerris F, Rosenberg PS, Frisch M.

J Natl Cancer Inst. 2003 Apr 2;95(7):532-9.

Items per page

Supplemental Content

Write to the Help Desk